Published in J Mol Biol on January 30, 2008
Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol (2009) 4.11
Retinoids regulate stem cell differentiation. J Cell Physiol (2011) 1.91
REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells. PLoS One (2010) 1.02
Polycomb recruitment attenuates retinoic acid-induced transcription of the bivalent NR2F1 gene. Nucleic Acids Res (2013) 0.87
Rex1 (Zfp42) null mice show impaired testicular function, abnormal testis morphology, and aberrant gene expression. Dev Biol (2011) 0.83
Embryonic stem cell factors undifferentiated transcription factor-1 (UFT-1) and reduced expression protein-1 (REX-1) are widely expressed in human skin and may be involved in cutaneous differentiation but not in stem cell fate determination. Int J Exp Pathol (2011) 0.78
Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells. J Cell Physiol (2010) 0.78
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Stat3 as an oncogene. Cell (1999) 17.39
STATs and gene regulation. Science (1997) 16.55
"Stemness": transcriptional profiling of embryonic and adult stem cells. Science (2002) 15.55
Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 15.33
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2003) 12.94
Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (1994) 11.33
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell (1980) 6.72
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell (1994) 6.45
STATs: signal transducers and activators of transcription. Cell (1996) 6.10
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell (2002) 5.44
Sp1- and Krüppel-like transcription factors. Genome Biol (2003) 5.42
What does Stat3 do? J Clin Invest (2002) 4.83
Stat proteins and oncogenesis. J Clin Invest (2002) 4.79
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55
A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia (2006) 4.39
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol (2004) 3.79
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol (2003) 3.45
Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol (2006) 3.39
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A (2001) 3.29
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene (2005) 3.05
STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol (2003) 3.04
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest (1998) 3.01
Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J (1999) 2.80
Stat3 regulates genes common to both wound healing and cancer. Oncogene (2005) 2.80
Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol (2002) 2.71
SOCS: physiological suppressors of cytokine signaling. J Cell Sci (2000) 2.69
STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A (1996) 2.64
Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature (1981) 2.62
STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci (2000) 2.60
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A (2000) 2.58
ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem (1999) 2.41
Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol (1998) 2.37
A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene. Proc Natl Acad Sci U S A (1989) 2.32
Mutations causing charge alterations in regulatory subunits of the cAMP-dependent protein kinase of cultured S49 lymphoma cells. Cell (1977) 2.20
Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity (1997) 2.18
Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development (1991) 2.11
Early retinoic acid-induced F9 teratocarcinoma stem cell gene ERA-1: alternate splicing creates transcripts for a homeobox-containing protein and one lacking the homeobox. Mol Cell Biol (1988) 2.10
Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A (2001) 2.09
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A (1999) 2.04
Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol (1998) 2.03
GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J (2003) 2.00
Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1983) 1.99
Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene (2005) 1.98
Cell-specific activity of the constituent elements of the simian virus 40 enhancer. Proc Natl Acad Sci U S A (1987) 1.97
STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther (2006) 1.96
Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol Cell Biol (1989) 1.91
Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol (1985) 1.87
The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci U S A (2003) 1.80
A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene (2006) 1.78
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene (2005) 1.78
Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci (1998) 1.77
Regulation and organization of adenylyl cyclases and cAMP. Biochem J (2003) 1.73
Negative regulators of cytokine signal transduction. Cell Mol Life Sci (1999) 1.71
cAMP effector mechanisms. Novel twists for an 'old' signaling system. FEBS Lett (2003) 1.62
Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci U S A (2003) 1.59
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene (2005) 1.55
Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation (2007) 1.48
SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J (2003) 1.47
Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci U S A (1993) 1.44
The roles of retinoids in vertebrate development. Annu Rev Biochem (1995) 1.44
Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem (2000) 1.42
Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J Biol Chem (2006) 1.41
Hematopoietic progenitors express neural genes. Proc Natl Acad Sci U S A (2003) 1.41
Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc Natl Acad Sci U S A (1995) 1.29
Activation of SOCS-3 by resistin. Mol Cell Biol (2005) 1.27
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. Blood (2001) 1.27
Adult stem cells: assessing the case for pluripotency. Trends Cell Biol (2002) 1.26
Retinoids and vertebrate development. J Biol Chem (1994) 1.26
The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog (2006) 1.24
Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol (2003) 1.22
Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells (2005) 1.22
Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J (1997) 1.19
Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood (2002) 1.18
Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest (1999) 1.17
Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Oncogene (2000) 1.16
Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Cancer Res (2004) 1.13
Functional characterization of cAMP-binding mutations in type I protein kinase. J Biol Chem (1989) 1.08
Elevated activity of STAT3C due to higher DNA binding affinity of phosphotyrosine dimer rather than covalent dimer formation. J Biol Chem (2006) 1.08
Transcriptional specificity of the pluripotent embryonic stem cell. Cell Growth Differ (1996) 1.07
Reactive oxygen species as mediators of cell adhesion. Ital J Biochem (2003) 1.05
Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer (2003) 1.05
Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3. Cancer Res (2007) 1.04
SOCS: suppressors of cytokine signalling. Int J Biochem Cell Biol (1998) 1.03
SOCS-3 induces myoblast differentiation. J Biol Chem (2005) 1.01
The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest (2001) 1.00
Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol Cell Endocrinol (2002) 0.95
Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leukemia. Leuk Lymphoma (2003) 0.95
cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. Mol Endocrinol (2001) 0.91
Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-A. Mol Endocrinol (1993) 0.90
Teratocarcinoma stem cells as a model for differentiation in the mouse embryo. Int J Dev Biol (1989) 0.90
Janus kinases and their role in growth and disease. Life Sci (1999) 0.89
SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation. J Biol Chem (2004) 0.89
Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Carcinogenesis (2005) 0.87
Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase. J Biol Chem (2006) 0.87
Hormonal regulation of pp60c-src expression during osteoclast formation in vitro. Mol Endocrinol (1993) 0.86
Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev (2009) 2.40
Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol (2011) 2.40
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res (2004) 2.07
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis (2007) 1.93
1.3-μm InAs/GaAs quantum-dot lasers monolithically grown on Si substrates using InAlAs/GaAs dislocation filter layers. Opt Express (2014) 1.82
Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. Cancer Res (2011) 1.75
Disruption of the lecithin:retinol acyltransferase gene makes mice more susceptible to vitamin A deficiency. J Biol Chem (2005) 1.67
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res (2005) 1.61
CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia. Cell Cycle (2013) 1.50
Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation (2007) 1.48
Epimorphic regeneration approach to tissue replacement in adult mammals. Proc Natl Acad Sci U S A (2009) 1.47
Overexpression of lecithin:retinol acyltransferase in the epithelial basal layer makes mice more sensitive to oral cavity carcinogenesis induced by a carcinogen. Cancer Biol Ther (2009) 1.47
Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis. Cancer Res (2013) 1.46
Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog (2011) 1.37
Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J Tissue Eng Regen Med (2008) 1.29
Epigenomic reorganization of the clustered Hox genes in embryonic stem cells induced by retinoic acid. J Biol Chem (2010) 1.26
The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog (2006) 1.24
Differences in gene expression between wild type and Hoxa1 knockout embryonic stem cells after retinoic acid treatment or leukemia inhibitory factor (LIF) removal. J Biol Chem (2005) 1.24
Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology (2004) 1.23
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther (2008) 1.20
Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. J Biol Chem (2007) 1.19
retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines. Cancer Res (2002) 1.17
Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol (2003) 1.13
Retinol saturase promotes adipogenesis and is downregulated in obesity. Proc Natl Acad Sci U S A (2009) 1.11
Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation. Dev Dyn (2009) 1.09
Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochem Pharmacol (2007) 1.06
Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts. J Biol Chem (2010) 1.05
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. Clin Cancer Res (2005) 1.04
Epigenetic regulation by RARα maintains ligand-independent transcriptional activity. Nucleic Acids Res (2011) 1.03
Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res (2013) 1.01
Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. Mol Cancer Ther (2005) 1.00
n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr (2008) 0.99
Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther (2008) 0.99
RARγ is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells. J Cell Sci (2012) 0.98
Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals. Chest (2010) 0.98
Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos. Dev Dyn (2003) 0.97
Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J Cell Physiol (2013) 0.96
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model. Biochem Pharmacol (2009) 0.96
A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Cancer Prev Res (Phila) (2009) 0.96
Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol Cell Endocrinol (2002) 0.95
Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Mol Cancer Res (2003) 0.95
Hoxa1 is required for the retinoic acid-induced differentiation of embryonic stem cells into neurons. J Neurosci Res (2008) 0.95
The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice. Regen Med (2010) 0.95
Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells. Exp Cell Res (2013) 0.94
Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res (2002) 0.93
Polycomb repressive complex 2 impedes intestinal cell terminal differentiation. J Cell Sci (2012) 0.92
Homeostasis of retinol in lecithin: retinol acyltransferase gene knockout mice fed a high retinol diet. Biochem Pharmacol (2008) 0.92
CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev Biol (2007) 0.91
Analysis of two distinct retinoic acid response elements in the homeobox gene Hoxb1 in transgenic mice. Dev Dyn (2002) 0.91
Retinoic acid receptors and GATA transcription factors activate the transcription of the human lecithin:retinol acyltransferase gene. Int J Biochem Cell Biol (2008) 0.91
Cell proliferation inhibition and alterations in retinol esterification induced by phytanic acid and docosahexaenoic acid. J Lipid Res (2006) 0.91
Retinoic acid inhibits leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J Cell Physiol (2004) 0.90
RARγ is required for correct deposition and removal of Suz12 and H2A.Z in embryonic stem cells. J Cell Physiol (2011) 0.89
Homozygous deletion of the CRABPI gene in AB1 embryonic stem cells results in increased CRABPII gene expression and decreased intracellular retinoic acid concentration. Arch Biochem Biophys (2003) 0.89
The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol (2013) 0.89
Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies. Cancer Biol Ther (2010) 0.88
Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Carcinogenesis (2005) 0.87
Polycomb recruitment attenuates retinoic acid-induced transcription of the bivalent NR2F1 gene. Nucleic Acids Res (2013) 0.87
Deletion of retinoic acid receptor β (RARβ) impairs pancreatic endocrine differentiation. Exp Cell Res (2013) 0.86
Overexpression of COUP-TF1 in murine embryonic stem cells reduces retinoic acid-associated growth arrest and increases extraembryonic endoderm gene expression. Differentiation (2008) 0.86
Patient use of dietary supplements: a clinician's perspective. Curr Med Res Opin (2008) 0.86
Altered epigenetic regulation of homeobox genes in human oral squamous cell carcinoma cells. Exp Cell Res (2013) 0.85
Selectivity of arsenite interaction with zinc finger proteins. Metallomics (2012) 0.85
Combating the drug resistance of cisplatin using a platinum prodrug based delivery system. Angew Chem Int Ed Engl (2012) 0.84
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma. J Immunother (2007) 0.84
Expression of cyclin d1 and its association with disease characteristics in bladder cancer. Anticancer Res (2013) 0.84
Structure, upstream promoter region, and functional domains of a mouse and human Mix paired-like homeobox gene. Gene (2002) 0.84
Basal stem cells contribute to squamous cell carcinomas in the oral cavity. Carcinogenesis (2013) 0.83
Rex1 (Zfp42) null mice show impaired testicular function, abnormal testis morphology, and aberrant gene expression. Dev Biol (2011) 0.83
The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC. Carcinogenesis (2013) 0.83
Estrogen receptor-β expression and pharmacological targeting in bladder cancer. Oncol Rep (2013) 0.83
Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. Exp Cell Res (2004) 0.83
The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. Subcell Biochem (2014) 0.83
Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer. Clin Cancer Res (2004) 0.83
Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells. Exp Hematol (2008) 0.82
Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Clin Cancer Res (2003) 0.82
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol. Mol Cell Endocrinol (2007) 0.82
Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective. J Am Coll Nutr (2008) 0.82
Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma. Cancer (2002) 0.82
Reduced lecithin:retinol acyltransferase expression in human breast cancer. Int J Oncol (2006) 0.81
Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp Cell Res (2007) 0.81
The androgen receptor and stem cell pathways in prostate and bladder cancers (review). Int J Oncol (2011) 0.81
Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice. J Nutr Biochem (2009) 0.80
The truncated Hoxa1 protein interacts with Hoxa1 and Pbx1 in stem cells. J Cell Biochem (2009) 0.80
Induction of murine embryonic stem cell differentiation by medicinal plant extracts. Exp Cell Res (2010) 0.80
Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. J Cell Physiol (2002) 0.79
Retinoic acid suppresses the canonical Wnt signaling pathway in embryonic stem cells and activates the noncanonical Wnt signaling pathway. Stem Cells (2014) 0.79
Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma. J Cell Physiol (2014) 0.79
Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells. J Cell Physiol (2010) 0.78
Dispelling the myths about omega-3 fatty acids. Postgrad Med (2008) 0.78
Retinoid receptor mRNA expression profiles in human bladder cancer specimens. Int J Oncol (2005) 0.77
Metabolism and regulation of gene expression by 4-oxoretinol versus all-trans retinoic acid in normal human mammary epithelial cells. J Cell Physiol (2009) 0.77
Structure elucidation of retinoids in biological samples using postsource decay laser desorption/ionization mass spectrometry after high-performance liquid chromatography separation. Anal Chem (2006) 0.76
The reaction of arsenite with proteins relies on solution conditions. Inorg Chem (2014) 0.76
Cytochrome p450 cyp26a1 alters spinal motor neuron subtype identity in differentiating embryonic stem cells. J Biol Chem (2013) 0.76
Unexpected helicity control and helix inversion: homochiral helical nanotubes consisting of an achiral ligand. Chem Commun (Camb) (2013) 0.75